Multiple China Biotech VC, PE Deals Kick Off A Strong Start To 2024

 
• By Dexter Jie Yan
  
funding
Venture capital and private quity funding for Chinese biotechs got off to a good start in January. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia